Follow-up of Oncology Patients After Hospitalization in ICU

NCT02398890 | Completed DMC

• 2 other identifiers: KI1209062013-A00683-42
• Study Type: observational
• Target: 309
• Locations: 1 country
• Sites: 1

Brief Summary

"Purpose: The overall prognosis of oncology patients admitted to intensive care has improved greatly in recent years, leading to a wider admission policy. Due to a decrease in mortality in intensive care, more and more patients returning oncological circuit for the continuation of treatment of the underlying disease The existence of sequelae after the ICU (Intensive Care Unit) stay, whether renal, cardiac, respiratory or other, may influence the continuation of the optimal anti -cancer treatments and thus reduce the chances of recovery or evolution without tumor progression. However, no studies have evaluated the effects of resuscitation on subsequent cancer treatment strategies. It would thus become better appreciate the long-term oncology patients discharged alive from the hospital after a stay in intensive care. Main purpose of research : Assess the feasibility of a anti-tumor therapy for patients with progressive solid tumors, after an intensive care stay for other reason than elective surgery monitoring or securing an invasive procedure. The possibility of making an anti -cancer treatment will be evaluated by the treating oncologist and classified total, partial or absent from that defined before or during the ICU stay Secondary objective of the research : Evaluate the percentage of patients discharged alive from the ICU and dying in the hospital. Evaluate survival, lifestyle and physical and psychological effects of these patients after discharge from the hospital over a period of one year. It is understood that all these secondary endpoints will interfere with the existence of an evolutionary neoplasia not only with the ICU stay. They will therefore be interpreted with caution. Study Type: observational Study Design: Prognostic study of routine care, national, prospective, cohort type "

Conditions

Cancer

Outcome Measures

Primary Outcomes (1)

• Proportion of patients with cancer admitted in ICU who will be eligible for optimal anti-cancer treatment after discharge from ICU

  Months12

Interventions

routine care OTHER

routine care

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

adult patients with active solid tumor out alive from the ICU and monitoring in oncology in the same hospital as the resuscitator investigator.

You may qualify if:

• Patient with progressive solid tumor hospitalized in intensive care and got out alive
• Oncology patients followed in the same hospital as the investigator resuscitator
• Age ≥ 18 years
• Affiliate of social insurance
• Agree to participate

You may not qualify if:

• Patient hospitalized for programed surgery
• Hospitalization for securing procedure
• Pregnancy or breastfeeding woman

Sponsors & Collaborators

• Assistance Publique - Hôpitaux de Paris: lead

Study Sites (1)

CHI Le Raincy-Montfermeil

Montfermeil, 93370, France

Location

MeSH Terms

Conditions

Neoplasms

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 19, 2014
• First Posted: March 26, 2015
• Study Start: January 1, 2015
• Primary Completion: December 1, 2017
• Study Completion: December 17, 2019
• Last Updated: January 13, 2021

Record last verified: 2018-01

Locations

FR (1)